Benzinga's Top Initiations By: Benzinga via Benzinga February 19, 2015 at 09:16 AM EST Analysts at Roth Capital initiated coverage on Spark Therapeutics, Inc. (NASDAQ: ONCE) with a Buy rating. The target price for Spark ... Read More >> Related Stocks: Healthequity Proto Labs Inc Spark Therap